Stock To Watch: NeoGenomics, Inc. (NASDAQ:NEO)


The leading market experts have placed a mean price target of $11.17 on NeoGenomics, Inc. (NASDAQ:NEO) stock. This price level, which is estimated to be attained in one-year, indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.04 a share for the upcoming quarter and $0.13 for the current fiscal.

Technical View

The technical analysis of NeoGenomics, Inc. plainly substantiates that the 50-day moving average of NeoGenomics, Inc. is $8.63, and stock is trading $-0.42 points away or -4.84% from its 50-day moving average of $8.63. Further it is trading $0.46 or +5.99% away its 200-day moving average of $7.75. NeoGenomics, Inc. (NASDAQ:NEO) 52-week high is $9.54 and the 52-week low is $5.49.

This explains if the stock moves $-1.33, it will post a 52-week high. In event of +49.54% decline, a 52-week low will be hit.

Taking the valuation aspect to emphasize the valuation of NeoGenomics, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, NeoGenomics, Inc. (NASDAQ:NEO) ratio came in at N/A.

The stock last ended the trading session at $8.21 and registered a market cap of $639.50M. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. NeoGenomics, Inc. (NASDAQ:NEO) PEG ratio is at 3.18.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 14 times, 1 visits today)